Open-mkt buys · 90d
$426.9K
8 trades · 1 insiders
Open-mkt sales · 90d
$108.7K
2 trades · 2 insiders
Net · 90d
$318.2K
Insiders on file
47
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| TANG KEVIN | 10% Owner | 31 | $1.94M | $54.4K | 2026-10-27 |
| TANG CAPITAL MANAGEMENT LLC | 10% Owner | 1 | $0 | $54.4K | 2026-08-26 |
| ARCH Venture Partners IX, L.P. | 10% Owner | 3 | $0 | $39.8K | 2026-07-01 |
| GILLIS STEVEN | 10% Owner | 15 | $3.20M | $39.8K | 2026-07-01 |
| Christensen James | Director | 3 | $0 | $0 | 2026-06-15 |
| Whiting Nancy | Director | 3 | $0 | $0 | 2026-06-15 |
| Lew Jennifer | Director | 3 | $0 | $0 | 2026-06-15 |
| Lim Jonathan E | Director | 8 | $0 | $0 | 2026-06-15 |
| Doebele Robert | Chief Medical Officer | 2 | $0 | $0 | 2026-01-23 |
| Oien Jessica | See Remarks | 17 | $0 | $0 | 2026-01-23 |
| Hassig Christian | Chief Scientific Officer | 13 | $0 | $0 | 2026-01-23 |
| Hornby Zachary | President & CEO | 11 | $0 | $0 | 2026-01-23 |
| HINKLE DAVID A | See Remarks | 2 | $0 | $0 | 2026-01-23 |
| Brennan Christine | Director | 2 | $0 | $0 | 2025-06-23 |
| Burow Kristina | Director, 10% Owner | 14 | $3.20M | $0 | 2025-06-23 |
| Rubin Jami | Chief Financial Officer | 7 | $0 | $0 | 2024-08-19 |
| Wagner Klaus W. | Chief Medical Officer | 11 | $0 | $0 | 2024-08-19 |
| Abdollahian Neil | Chief Business Officer | 11 | $0 | $0 | 2024-08-19 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 4 | $0 | $0 | 2024-04-02 |
| ARCH Venture Partners IX, LLC | 10% Owner | 12 | $3.20M | $0 | 2024-04-02 |
| Kolchinsky Peter | 10% Owner | 8 | $5.00M | $0 | 2024-04-02 |
| Meltz Mark A | SVP, General Counsel | 5 | $0 | $0 | 2020-01-15 |
| Mosbrooker Eric | SVP, Chief Commercial Officer | 5 | $0 | $0 | 2020-01-15 |
| Conner Edward R. | SVP, Chief Medical Officer | 5 | $0 | $0 | 2020-01-15 |
| Jarrett Jennifer | Director | 8 | $0 | $0 | 2020-01-15 |
| Morrison Scott W | Director | 9 | $0 | $0 | 2020-01-15 |
| Schuetz Thomas J. | Director | 11 | $0 | $0 | 2020-01-15 |
| Holles Natalie C. | Senior Vice President, COO | 33 | $0 | $0 | 2020-01-15 |
| Smith Julie | Director | 8 | $0 | $0 | 2020-01-15 |
| Goldberg Mark Alan | Director | 9 | $0 | $0 | 2020-01-15 |
| Soloway Thomas P | Senior Vice President, CFO | 21 | $0 | $0 | 2020-01-15 |
| Patterson Matthew R | President & CEO | 83 | $0 | $7.92M | 2020-01-15 |
| LANGE LOUIS G | Director | 87 | $0 | $9.35M | 2020-01-15 |
| PRASAD SUYASH | Senior VP & Chief Med Officer | 47 | $0 | $2.12M | 2019-06-05 |
| NEWMAN MARY | SVP, Regulatory Affairs | 23 | $0 | $1.12M | 2018-11-15 |
| GRAY JOHN T. | Senior Vice President, R & D | 5 | $0 | $3.5K | 2018-09-28 |
| Nagler David | SVP, HR & Corp. Affairs | 13 | $0 | $432.7K | 2018-06-20 |
| PARMAR KUSH | Director | 3 | $0 | $0 | 2018-06-08 |
| OrbiMed Capital GP IV LLC | 10% Owner | 9 | $0 | $5.58M | 2018-03-12 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 13 | $500.0K | $15.21M | 2018-03-06 |
| SQUINTO STEPHEN P | Director | 2 | $0 | $0 | 2017-10-08 |
| ISALY SAMUEL D | 10% Owner | 1 | $0 | $18.98M | 2017-09-29 |
| 5AM Partners III, LLC | Other | 16 | $3.55M | $0 | 2017-04-24 |
| Woiwode Thomas | Director | 15 | $525.0K | $0 | 2016-08-24 |
| SILVERSTEIN JONATHAN | Director, 10% Owner | 10 | $500.0K | $0 | 2016-08-24 |
| Versant Ventures IV, LLC | 10% Owner | 14 | $525.0K | $0 | 2016-07-25 |
| Deerfield Special Situations Fund, L.P. | 10% Owner | 10 | $6.00M | $0 | 2016-07-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| TANG KEVIN | 10% Owner | P Buy | 2026-10-27 | 2026-10-29 | 10,707 | $2.40 | $25.7K | 3,022,456 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-26 | 2026-10-26 | 9,606 | $2.38 | $22.9K | 3,011,749 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-23 | 2026-10-26 | 6,234 | $2.38 | $14.8K | 3,002,143 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-22 | 2026-10-26 | 5,800 | $2.40 | $13.9K | 2,995,909 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-20 | 2026-10-20 | 220 | $2.37 | $521 | 2,990,109 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-19 | 2026-10-20 | 18,279 | $2.33 | $42.6K | 2,989,889 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-19 | 2026-10-20 | 12,790 | $2.34 | $29.9K | 2,971,610 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-10-16 | 2026-10-20 | 118,185 | $2.34 | $276.6K | 2,958,820 | SEC↗ |
| TANG CAPITAL MANAGEMENT LLC | 10% Owner | S Sale | 2026-08-26 | 2026-08-28 | 18,300 | $2.97 | $54.4K | 2,840,635 | SEC↗ |
| TANG KEVIN | 10% Owner | S Sale | 2026-08-26 | 2026-08-28 | 18,300 | $2.97 | $54.4K | 2,840,635 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-21 | 2026-07-21 | 2,975 | $2.44 | $7.3K | 2,858,935 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-20 | 2026-07-21 | 1,623 | $2.44 | $4.0K | 2,855,960 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-17 | 2026-07-21 | 265 | $2.44 | $647 | 2,854,337 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-16 | 2026-07-16 | 18,491 | $2.44 | $45.1K | 2,854,072 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-15 | 2026-07-16 | 1,600 | $2.44 | $3.9K | 2,835,581 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-14 | 2026-07-16 | 43,878 | $2.43 | $106.6K | 2,833,981 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-13 | 2026-07-13 | 48,211 | $2.42 | $116.7K | 2,790,103 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-10 | 2026-07-13 | 43,367 | $2.43 | $105.4K | 2,741,892 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-09 | 2026-07-13 | 7 | $2.48 | $17 | 2,698,525 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-08 | 2026-07-08 | 14,338 | $2.46 | $35.3K | 2,698,518 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-07 | 2026-07-08 | 15,810 | $2.48 | $39.2K | 2,684,180 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-06 | 2026-07-08 | 27,062 | $2.49 | $67.4K | 2,668,370 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-02 | 2026-07-02 | 9,821 | $2.49 | $24.5K | 2,641,308 | SEC↗ |
| ARCH Venture Partners IX, L.P. | 10% Owner | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-07-01 | 2026-07-02 | 71,612 | $2.49 | $178.3K | 2,631,487 | SEC↗ |
| ARCH Venture Partners IX, L.P. | 10% Owner | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| ARCH Venture Partners IX, L.P. | 10% Owner | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| GILLIS STEVEN | 10% Owner | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-30 | 2026-07-02 | 100 | $2.50 | $250 | 2,559,875 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-30 | 2026-07-02 | 25,930 | $2.54 | $65.9K | 2,559,775 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-29 | 2026-06-29 | 63,985 | $2.47 | $158.0K | 2,533,068 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-29 | 2026-06-29 | 777 | $2.48 | $1.9K | 2,533,845 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-26 | 2026-06-29 | 134 | $2.54 | $340 | 2,469,083 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-26 | 2026-06-29 | 75,047 | $2.55 | $191.4K | 2,468,949 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-25 | 2026-06-29 | 145,880 | $2.48 | $361.8K | 2,393,392 | SEC↗ |
| TANG KEVIN | 10% Owner | P Buy | 2026-06-25 | 2026-06-29 | 510 | $2.56 | $1.3K | 2,393,902 | SEC↗ |
| Lew Jennifer | Director | A Award deriv | 2026-06-15 | 2026-06-15 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Christensen James | Director | A Award deriv | 2026-06-15 | 2026-06-15 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Lim Jonathan E | Director | A Award deriv | 2026-06-15 | 2026-06-15 | 48,000 | — | $0 | 48,000 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2026-06-15 | 2026-06-15 | 32,000 | — | $0 | 32,000 | SEC↗ |
| HINKLE DAVID A | See Remarks | A Award deriv | 2026-01-23 | 2026-01-26 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2026-01-23 | 2026-01-26 | 600,000 | — | $0 | 600,000 | SEC↗ |
| Doebele Robert | Chief Medical Officer | A Award deriv | 2026-01-23 | 2026-01-26 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2026-01-23 | 2026-01-26 | 230,000 | — | $0 | 230,000 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2026-01-23 | 2026-01-26 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Burow Kristina | Director, 10% Owner | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Lim Jonathan E | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Lew Jennifer | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Christensen James | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Brennan Christine | Director | A Award deriv | 2025-06-23 | 2025-06-23 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Doebele Robert | Chief Medical Officer | A Award deriv | 2025-02-03 | 2025-02-03 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2025-01-22 | 2025-01-23 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2025-01-22 | 2025-01-23 | 295,000 | — | $0 | 295,000 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2025-01-22 | 2025-01-23 | 95,000 | — | $0 | 95,000 | SEC↗ |
| HINKLE DAVID A | See Remarks | A Award deriv | 2025-01-22 | 2025-01-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Rubin Jami | Chief Financial Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 32,468 | — | $0 | 0 | SEC↗ |
| Rubin Jami | Chief Financial Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 51,420 | — | $0 | 51,420 | SEC↗ |
| Rubin Jami | Chief Financial Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 196,666 | — | $0 | 196,666 | SEC↗ |
| Rubin Jami | Chief Financial Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 32,468 | — | $0 | 32,468 | SEC↗ |
| Rubin Jami | Chief Financial Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 51,420 | — | $0 | 0 | SEC↗ |
| Rubin Jami | Chief Financial Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 196,666 | — | $0 | 0 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 41,745 | — | $0 | 0 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 68,080 | — | $0 | 68,080 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 94,871 | — | $0 | 94,871 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 9,635 | — | $0 | 9,635 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 102,564 | — | $0 | 102,564 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 41,745 | — | $0 | 41,745 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 68,080 | — | $0 | 0 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 94,871 | — | $0 | 0 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 9,635 | — | $0 | 0 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 102,564 | — | $0 | 0 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 82,051 | — | $0 | 82,051 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 23,191 | — | $0 | 23,191 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 36,852 | — | $0 | 36,852 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 54,871 | — | $0 | 54,871 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 19,948 | — | $0 | 19,948 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 82,051 | — | $0 | 0 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 23,191 | — | $0 | 0 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 36,852 | — | $0 | 0 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 54,871 | — | $0 | 0 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 19,948 | — | $0 | 0 | SEC↗ |
| Hornby Zachary | President & CEO | D To issuer deriv | 2024-08-19 | 2024-08-20 | 256,410 | — | $0 | 0 | SEC↗ |
| Hornby Zachary | President & CEO | D To issuer deriv | 2024-08-19 | 2024-08-20 | 471,282 | — | $0 | 0 | SEC↗ |
| Hornby Zachary | President & CEO | D To issuer deriv | 2024-08-19 | 2024-08-20 | 257,207 | — | $0 | 0 | SEC↗ |
| Hornby Zachary | President & CEO | D To issuer deriv | 2024-08-19 | 2024-08-20 | 162,343 | — | $0 | 0 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2024-08-19 | 2024-08-20 | 256,410 | — | $0 | 256,410 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2024-08-19 | 2024-08-20 | 471,282 | — | $0 | 471,282 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2024-08-19 | 2024-08-20 | 257,207 | — | $0 | 257,207 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2024-08-19 | 2024-08-20 | 162,343 | — | $0 | 162,343 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 16,234 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 35,897 | — | $0 | 35,897 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 16,234 | — | $0 | 16,234 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 32,051 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 29,148 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 26,090 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 35,897 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 42,051 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 29,148 | — | $0 | 29,148 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 32,051 | — | $0 | 32,051 | SEC↗ |
| Oien Jessica | See Remarks | D To issuer deriv | 2024-08-19 | 2024-08-20 | 10,200 | — | $0 | 0 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 10,200 | — | $0 | 10,200 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 42,051 | — | $0 | 42,051 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-08-19 | 2024-08-20 | 26,090 | — | $0 | 26,090 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 94,871 | — | $0 | 94,871 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 76,173 | — | $0 | 76,173 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 48,703 | — | $0 | 48,703 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 48,703 | — | $0 | 0 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 76,173 | — | $0 | 0 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 94,871 | — | $0 | 0 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 62,820 | — | $0 | 0 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | D To issuer deriv | 2024-08-19 | 2024-08-20 | 10,256 | — | $0 | 0 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 62,820 | — | $0 | 62,820 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 10,256 | — | $0 | 10,256 | SEC↗ |
| Lim Jonathan E | Director | A Award deriv | 2024-06-20 | 2024-06-20 | 6,610 | — | $0 | 6,610 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-02 | 3,703,704 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-02 | 7,142,857 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 3,000,000 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 17,000,000 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 13,964,285 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 2,464,286 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| Lim Jonathan E | Director | C Conversion deriv | 2024-04-02 | 2024-04-04 | 5,128 | — | $0 | 0 | SEC↗ |
| Lim Jonathan E | Director | C Conversion deriv | 2024-04-02 | 2024-04-04 | 512,820 | — | $0 | 0 | SEC↗ |
| Lim Jonathan E | Director | C Conversion deriv | 2024-04-02 | 2024-04-04 | 7,326 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2024-04-02 | 2024-04-02 | 189,933 | — | $0 | 189,933 | SEC↗ |
| Wellington Biomedical Innovati | 10% Owner | C Conversion | 2024-04-02 | 2024-04-02 | 366,300 | — | $0 | 556,233 | SEC↗ |
| Kolchinsky Peter | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 296,875 | $16.00 | $4.75M | 1,884,787 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 280,219 | — | $0 | 280,219 | SEC↗ |
| Kolchinsky Peter | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 15,625 | $16.00 | $250.0K | 295,844 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 1,587,912 | — | $0 | 1,587,912 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| ARCH Venture Partners IX, LLC | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| GILLIS STEVEN | 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| GILLIS STEVEN | 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| Lim Jonathan E | Director | C Conversion | 2024-04-02 | 2024-04-04 | 525,274 | — | $0 | 550,915 | SEC↗ |
| Burow Kristina | Director, 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| Burow Kristina | Director, 10% Owner | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| Burow Kristina | Director, 10% Owner | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| Hassig Christian | Chief Scientific Officer | A Award deriv | 2024-03-27 | 2024-03-29 | 48,703 | — | $0 | 48,703 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2024-03-27 | 2024-03-29 | 13,219 | — | $0 | 13,219 | SEC↗ |
| Abdollahian Neil | Chief Business Officer | A Award deriv | 2024-03-27 | 2024-03-29 | 23,191 | — | $0 | 23,191 | SEC↗ |
| Hornby Zachary | President & CEO | A Award deriv | 2024-03-27 | 2024-03-29 | 162,343 | — | $0 | 162,343 | SEC↗ |
| Burow Kristina | Director, 10% Owner | A Award deriv | 2024-03-27 | 2024-03-29 | 26,438 | — | $0 | 26,438 | SEC↗ |
| Brennan Christine | Director | A Award deriv | 2024-03-27 | 2024-03-29 | 26,438 | — | $0 | 26,438 | SEC↗ |
| Oien Jessica | See Remarks | A Award deriv | 2024-03-27 | 2024-03-29 | 16,234 | — | $0 | 16,234 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2024-03-27 | 2024-03-29 | 41,745 | — | $0 | 41,745 | SEC↗ |
| Christensen James | Director | A Award deriv | 2024-03-27 | 2024-03-29 | 13,219 | — | $0 | 13,219 | SEC↗ |
| Rubin Jami | Chief Financial Officer | A Award deriv | 2024-03-27 | 2024-03-29 | 32,468 | — | $0 | 32,468 | SEC↗ |
| Lew Jennifer | Director | A Award deriv | 2024-03-27 | 2024-03-29 | 13,219 | — | $0 | 13,219 | SEC↗ |
| Lim Jonathan E | Director | A Award deriv | 2024-03-27 | 2024-03-29 | 13,219 | — | $0 | 13,219 | SEC↗ |
| Conner Edward R. | SVP, Chief Medical Officer | D To issuer deriv | 2020-01-15 | 2020-01-15 | 90,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Goldberg Mark Alan | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 4,500 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 50,105 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 40,883 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 93,109 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 25,000 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 548 | — | $0 | 0 | SEC↗ |
| Holles Natalie C. | President and COO | D To issuer deriv | 2020-01-15 | 2020-01-15 | 110,703 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| LANGE LOUIS G | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| LANGE LOUIS G | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| LANGE LOUIS G | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| LANGE LOUIS G | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| Meltz Mark A | SVP, General Counsel | D To issuer deriv | 2020-01-15 | 2020-01-15 | 104,000 | — | $0 | 0 | SEC↗ |
| Morrison Scott W | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 33,635 | — | $0 | 0 | SEC↗ |
| Morrison Scott W | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| Morrison Scott W | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Morrison Scott W | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Morrison Scott W | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Mosbrooker Eric | SVP, Chief Commercial Office | D To issuer deriv | 2020-01-15 | 2020-01-15 | 87,750 | — | $0 | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | D To issuer deriv | 2020-01-15 | 2020-01-15 | 143,569 | — | $0 | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | D To issuer deriv | 2020-01-15 | 2020-01-15 | 188,334 | — | $0 | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | D To issuer deriv | 2020-01-15 | 2020-01-15 | 177,450 | — | $0 | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | D To issuer deriv | 2020-01-15 | 2020-01-15 | 225,000 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,086 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 5,605 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Schuetz Thomas J. | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| Smith Julie | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Smith Julie | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 16,200 | — | $0 | 0 | SEC↗ |
| Smith Julie | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 9,000 | — | $0 | 0 | SEC↗ |
| Smith Julie | Director | D To issuer deriv | 2020-01-15 | 2020-01-15 | 18,000 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | D To issuer deriv | 2020-01-15 | 2020-01-15 | 6,263 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | D To issuer deriv | 2020-01-15 | 2020-01-15 | 73,781 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | D To issuer deriv | 2020-01-15 | 2020-01-15 | 3,829 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | D To issuer deriv | 2020-01-15 | 2020-01-15 | 65,000 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | D To issuer deriv | 2020-01-15 | 2020-01-15 | 75,000 | — | $0 | 0 | SEC↗ |
| Conner Edward R. | SVP, Chief Medical Officer | U Tender | 2020-01-15 | 2020-01-15 | 24,584 | $60.00 | $1.48M | 0 | SEC↗ |
| Goldberg Mark Alan | Director | U Tender | 2020-01-15 | 2020-01-15 | 1,500 | $60.00 | $90.0K | 0 | SEC↗ |
| Holles Natalie C. | President and COO | U Tender | 2020-01-15 | 2020-01-15 | 104,439 | $60.00 | $6.27M | 0 | SEC↗ |
| LANGE LOUIS G | Director | U Tender | 2020-01-15 | 2020-01-15 | 32,343 | $60.00 | $1.94M | 0 | SEC↗ |
| LANGE LOUIS G | Director | U Tender | 2020-01-15 | 2020-01-15 | 13,678 | $60.00 | $820.7K | 0 | SEC↗ |
| LANGE LOUIS G | Director | U Tender | 2020-01-15 | 2020-01-15 | 265,799 | $60.00 | $15.95M | 0 | SEC↗ |
| LANGE LOUIS G | Director | U Tender | 2020-01-15 | 2020-01-15 | 3,555 | $60.00 | $213.3K | 0 | SEC↗ |
| Meltz Mark A | SVP, General Counsel | U Tender | 2020-01-15 | 2020-01-15 | 32,705 | $60.00 | $1.96M | 0 | SEC↗ |
| Mosbrooker Eric | SVP, Chief Commercial Office | U Tender | 2020-01-15 | 2020-01-15 | 26,919 | $60.00 | $1.62M | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | U Tender | 2020-01-15 | 2020-01-15 | 261,458 | $60.00 | $15.69M | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | U Tender | 2020-01-15 | 2020-01-15 | 171,814 | $60.00 | $10.31M | 0 | SEC↗ |
| Schuetz Thomas J. | Director | U Tender | 2020-01-15 | 2020-01-15 | 89,695 | $60.00 | $5.38M | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | U Tender | 2020-01-15 | 2020-01-15 | 183,384 | $60.00 | $11.00M | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2020-01-08 | 2020-01-10 | 64,751 | — | $0 | 0 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2020-01-08 | 2020-01-10 | 11,824 | — | $0 | 143,569 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2020-01-08 | 2020-01-10 | 11,666 | — | $0 | 188,334 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2020-01-08 | 2020-01-10 | 74,297 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise deriv | 2020-01-08 | 2020-01-10 | 6,219 | — | $0 | 73,781 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise deriv | 2020-01-08 | 2020-01-10 | 144,669 | — | $0 | 3,829 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2020-01-08 | 2020-01-10 | 11,666 | $15.26 | $178.0K | 261,458 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2020-01-08 | 2020-01-10 | 11,824 | $9.50 | $112.3K | 249,792 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2020-01-08 | 2020-01-10 | 64,751 | $0.78 | $50.5K | 163,671 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2020-01-08 | 2020-01-10 | 74,297 | $2.19 | $162.7K | 237,968 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise | 2020-01-08 | 2020-01-10 | 6,219 | $15.26 | $94.9K | 183,384 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise | 2020-01-08 | 2020-01-10 | 144,669 | $2.76 | $399.3K | 177,165 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | G Gift | 2019-12-26 | 2020-01-10 | 12,500 | — | $0 | 98,920 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-12-23 | 2019-12-27 | 1,000 | $59.60 | $59.6K | 13,678 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-12-23 | 2019-12-27 | 10,000 | $59.60 | $596.0K | 265,799 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise deriv | 2019-12-12 | 2019-12-16 | 5,715 | — | $0 | 548 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise deriv | 2019-12-12 | 2019-12-16 | 74,117 | — | $0 | 40,883 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise deriv | 2019-12-12 | 2019-12-16 | 6,891 | — | $0 | 93,109 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise deriv | 2019-12-12 | 2019-12-16 | 14,895 | — | $0 | 50,105 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise deriv | 2019-12-12 | 2019-12-16 | 45,726 | — | $0 | 110,703 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise deriv | 2019-12-12 | 2019-12-16 | 41,321 | — | $0 | 148,498 | SEC↗ |
| Conner Edward R. | SVP, Chief Medical Officer | F Tax w/h | 2019-12-12 | 2019-12-16 | 5,416 | $59.37 | $321.5K | 24,584 | SEC↗ |
| Holles Natalie C. | President and COO | F Tax w/h | 2019-12-12 | 2019-12-16 | 8,681 | $59.37 | $515.4K | 46,023 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise | 2019-12-12 | 2019-12-16 | 45,726 | $2.76 | $126.2K | 91,749 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise | 2019-12-12 | 2019-12-16 | 5,715 | $9.50 | $54.3K | 97,464 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise | 2019-12-12 | 2019-12-16 | 6,891 | $27.39 | $188.7K | 178,472 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise | 2019-12-12 | 2019-12-16 | 14,895 | $24.74 | $368.5K | 193,367 | SEC↗ |
| Holles Natalie C. | President and COO | F Tax w/h | 2019-12-12 | 2019-12-16 | 88,928 | $59.37 | $5.28M | 104,439 | SEC↗ |
| Holles Natalie C. | President and COO | M Exercise | 2019-12-12 | 2019-12-16 | 74,117 | $15.26 | $1.13M | 171,581 | SEC↗ |
| Meltz Mark A | SVP, General Counsel | F Tax w/h | 2019-12-12 | 2019-12-16 | 4,628 | $59.37 | $274.8K | 32,705 | SEC↗ |
| Mosbrooker Eric | SVP, Chief Commercial Office | F Tax w/h | 2019-12-12 | 2019-12-16 | 4,881 | $59.37 | $289.8K | 26,919 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | F Tax w/h | 2019-12-12 | 2019-12-16 | 8,681 | $59.37 | $515.4K | 12,633 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | M Exercise | 2019-12-12 | 2019-12-16 | 41,321 | $2.76 | $114.0K | 53,954 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | F Tax w/h | 2019-12-12 | 2019-12-16 | 21,458 | $59.37 | $1.27M | 32,496 | SEC↗ |
| Holles Natalie C. | President and COO | F Tax w/h | 2019-12-05 | 2019-12-09 | 505 | $59.21 | $29.9K | 54,704 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | F Tax w/h | 2019-12-05 | 2019-12-09 | 1,974 | $59.21 | $116.9K | 111,420 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | F Tax w/h | 2019-12-05 | 2019-12-09 | 505 | $59.21 | $29.9K | 21,314 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2019-11-08 | 2019-11-12 | 14,426 | — | $0 | 155,393 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2019-11-08 | 2019-11-12 | 14,426 | $9.50 | $137.0K | 127,820 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | S Sale | 2019-11-08 | 2019-11-12 | 14,426 | $30.00 | $432.8K | 113,394 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-09-23 | 2019-09-25 | 9,755 | $32.15 | $313.6K | 276,044 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-09-23 | 2019-09-25 | 1,000 | $32.18 | $32.2K | 14,678 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-09-23 | 2019-09-25 | 245 | $32.66 | $8.0K | 275,799 | SEC↗ |
| Holles Natalie C. | President and COO | F Tax w/h | 2019-09-05 | 2019-09-09 | 505 | $31.02 | $15.7K | 55,209 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | F Tax w/h | 2019-09-05 | 2019-09-09 | 1,974 | $31.02 | $61.2K | 113,394 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | F Tax w/h | 2019-09-05 | 2019-09-09 | 505 | $31.02 | $15.7K | 21,819 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise deriv | 2019-08-12 | 2019-08-14 | 20,000 | — | $0 | 169,819 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | S Sale | 2019-08-12 | 2019-08-14 | 19,000 | $34.02 | $646.4K | 116,368 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | S Sale | 2019-08-12 | 2019-08-14 | 1,000 | $34.53 | $34.5K | 115,368 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | M Exercise | 2019-08-12 | 2019-08-14 | 20,000 | $9.50 | $190.0K | 135,368 | SEC↗ |
| Conner Edward R. | SVP, Chief Medical Officer | A Award deriv | 2019-07-15 | 2019-07-17 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Conner Edward R. | SVP, Chief Medical Officer | A Award | 2019-07-15 | 2019-07-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-06-24 | 2019-06-26 | 600 | $40.00 | $24.0K | 285,799 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-06-24 | 2019-06-26 | 15,798 | $37.60 | $594.0K | 290,001 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-06-24 | 2019-06-26 | 800 | $37.89 | $30.3K | 15,878 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-06-24 | 2019-06-26 | 200 | $39.46 | $7.9K | 15,678 | SEC↗ |
| LANGE LOUIS G | Director | S Sale | 2019-06-24 | 2019-06-26 | 3,602 | $38.15 | $137.4K | 286,399 | SEC↗ |
| Soloway Thomas P | Executive Vice President, CF | F Tax w/h | 2019-06-05 | 2019-06-07 | 1,009 | $37.31 | $37.6K | 22,324 | SEC↗ |
| Holles Natalie C. | President and COO | F Tax w/h | 2019-06-05 | 2019-06-07 | 1,009 | $37.31 | $37.6K | 55,714 | SEC↗ |
| Patterson Matthew R | Chief Executive Officer | F Tax w/h | 2019-06-05 | 2019-06-07 | 3,332 | $37.31 | $124.3K | 115,368 | SEC↗ |
| PRASAD SUYASH | Senior VP & Chief Med Office | F Tax w/h | 2019-06-05 | 2019-06-07 | 757 | $37.31 | $28.2K | 17,479 | SEC↗ |